© Springer-Verlag London 2015Vinod H. Nargund, Derek Raghavan and Howard M. Sandler (eds.)Urological Oncology10.1007/978-0-85729-482-1_10 10. Diet and GU Cancers Ali Panah1 and Chandran Tanabalan1 (1) Department of Urology, Homerton University Hospital NHS Trust, Homerton Row, London, E9 6SR,…
Organ No. of cases in 2012 (in 1,000s) Percent of all cancers Prostate 1,112 7.9 Testis 55 0.4 Kidney 338 2.4 Bladder 430 3.1 Based on data from Ref. [2]…
© Springer-Verlag London 2015Vinod H. Nargund, Derek Raghavan and Howard M. Sandler (eds.)Urological Oncology10.1007/978-0-85729-482-1_2 2. Experimental Urological Oncology: Cellular, Molecular, and Animal Prabhakar Rajan1 and Hing Yip Leung2 (1) Institue of Cancer Science, University of Glasgow, Glasgow, Strathclyde, UK…
, Said Abdallah Al-Mamari1 and Salim Said Al-Busaidy1 (1) Urology Department, The Royal Hospital, Muscat, Oman Said Abdallah Al-Mamari Email: sabdal67@yahoo.com 29.1 Prostate Cancer 1. An 88-year-old man develops castration-resistant prostate cancer (CRPC) after…
Fig. 16.1 Clinical behaviour and management of a T1a renal mass [1, 2] SRMs are slow growing, and the average growth rate of RCC is 0.28 cm/year. They seldom progress…
Fig. 6.1 (a, b) Laparoscopic views of peritoneal carcinomatosis with the characteristic numerous white nodules on both parietal and visceral peritoneum (This was seen 2 months after a history of…
Fig. 4.1 Pyramid of the primary treatment of the prostate cancer 4.1.1 Localized Disease This includes all the tumours not extending beyond the prostate capsule, that is, cT1-T2, N0, M0…
Fig. 15.1 (a–e) CT scan pre- and post-contrast showing a small tumour (x) before injection (a), in arterial time (b, c) and venous time (d, e) (Courtesy of S. Novellas,…
Fig. 3.1 Fusion of prerecorded MRI data with real-time U/S (Urostation®, Keolis): the blue net is an MRI 3-D reconstruction of U/S information collected before the procedure, delineating the whole…
1. Clear cell renal cell carcinoma (CCRCC) 2. Multilocular clear cell renal cell carcinoma 3. Papillary renal cell carcinoma (PRCC) 4. Chromophobe renal cell carcinoma (ChRCC) 5. Carcinoma of collecting…
